Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-12

Clinical Trial Update: Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the efficacy of extended infusion beta-lactam antibiotics for febrile neutropenia in hematologic patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital Universitari de Bellvitge | Conditions: Febrile Neutropenia | Phase 4 | Status: UNKNOWN